What is it about?
We evaluate the efficacy and safety of citalopram, a potent and highly selective serotonin reuptake inhibitor (SSRI) antidepressant, in patients with premature ejaculation (PE).
Photo by Marcelo Leal on Unsplash
Why is it important?
In general, the prevalence of premature ejaculation (PE) is reported as being between 22 and 38% in the adult male population, and up to almost 40% of men experience the problem on a recurring basis.
Read the Original
This page is a summary of: Safety and efficacy of citalopram in the treatment of premature ejaculation: a double-blind placebo-controlled, fixed dose, randomized study, International Journal of Impotence Research, August 2005, Springer Science + Business Media, DOI: 10.1038/sj.ijir.3901384.
You can read the full text:
The following have contributed to this page